Whole-cell patch clamp was conducted as described (Zhou, et al. 2015). Briefly, NMDG-Cl solutions were used to isolate Cl− currents from UM-SCC-1 cells overexpressing TMEM16A (bath solution was 140mM NMDG-Cl, 10mM HEPES, 1mM MgCl2, 1.5mM CaCl2, 5mM glucose; pipette solution was 140mM NMDG-Cl, 10mM HEPES, 1mM MgCl2, 5mM glucose, 1mM EGTA, 1mM Mg-ATP, and 0.1mM Na-GTP). Membrane current (Im) was measured using a periodic current-voltage (I/V) protocol, which stepped the holding potential from 100 to +100 mV in 20 mV steps. Bath solution ± agonists heated to 37° C was perfused over the cell at 2 ml/min. The percent change in Im was calculated at the 60 mV holding potential. All cells tested exhibited outward rectified I/V curves with a reversal potential equal to the Cl− equilibrium potential, consistent with TMEM 16A activity.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.